0
CME   Premorbid IQ in Schizophrenia: A Meta-Analytic Review
Kristen A. Woodberry, M.S.W., A.M.; Anthony J. Giuliano, Ph.D.; Larry J. Seidman, Ph.D.
CME   Cost-Effectiveness of Treatments for Adolescent Depression: Results From TADS
Marisa Elena Domino, Ph.D.; Barbara J. Burns, Ph.D.; Susan G. Silva, Ph.D.; Christopher J. Kratochvil, M.D.; Benedetto Vitiello, M.D.; Mark A. Reinecke, Ph.D.; Jeremy Mario, M.B.A.; John S. March, M.D., M.P.H.
Stimulant Therapy and Risk for Subsequent Substance Use Disorders in Male Adults With ADHD: A Naturalistic Controlled 10-Year Follow-Up Study
Joseph Biederman, M.D.; Michael C. Monuteaux, Sc.D.; Thomas Spencer, M.D.; Timothy E. Wilens, M.D.; Heather A. MacPherson, B.A.; Stephen V. Faraone, Ph.D.
Age of Methylphenidate Treatment Initiation in Children With ADHD and Later Substance Abuse: Prospective Follow-Up Into Adulthood
Salvatore Mannuzza, Ph.D.; Rachel G. Klein, Ph.D.; Nhan L. Truong, M.A.; John L. Moulton, III, Ph.D.; Erica R. Roizen, B.A.; Kathryn H. Howell, B.S.; Francisco X. Castellanos, M.D.
Association of the Neurotrophic Tyrosine Kinase Receptor 3 (NTRK3) Gene and Childhood-Onset Mood Disorders
Yu Feng, B.Sc.; Ágnes Vetró, M.D.; Eniko Kiss, M.D.; Krisztina Kapornai, M.D.; Gabriella Daróczi, M.D.; László Mayer, M.D.; Zsuzsanna Tamás, M.D.; Ildikó Baji, M.D.; Júlia Gádoros, M.D.; Nicole King, B.Sc.; James L. Kennedy, M.D.; Karen Wigg, B.Sc.; Maria Kovacs, Ph.D.; Cathy L. Barr, Ph.D.; International Consortium for Childhood-Onset Mood Disorders
A 6-Week Randomized, Placebo-Controlled Trial of CP-316,311 (a Selective CRH1 Antagonist) in the Treatment of Major Depression
Brendon Binneman, M.B.Ch.B., M.R.C.Psych.; Douglas Feltner, M.D.; Sheela Kolluri, Ph.D.; Yuanjun Shi, Ph.D.; Ruolun Qiu, Ph.D.; Thomas Stiger, Ph.D.
A Randomized, Controlled Trial of Cognitive-Behavioral Therapy for Augmenting Pharmacotherapy in Obsessive-Compulsive Disorder
Helen Blair Simpson, M.D., Ph.D.; Edna B. Foa, Ph.D.; Michael R. Liebowitz, M.D.; Deborah Roth Ledley, Ph.D.; Jonathan D. Huppert, Ph.D.; Shawn Cahill, Ph.D.; Donna Vermes, M.S., N.P.P.; Andrew B. Schmidt, L.C.S.W.; Elizabeth Hembree, Ph.D.; Martin Franklin, Ph.D.; Raphael Campeas, M.D.; Chang-Gyu Hahn, M.D., Ph.D.; Eva Petkova, Ph.D.
The Other-Race Effect in Face Processing Among African American and Caucasian Individuals With Schizophrenia
Amy E. Pinkham, Ph.D.; Noah J. Sasson, Ph.D.; Monica E. Calkins, Ph.D.; Jan Richard, M.S.; Paul Hughett, Ph.D.; Raquel E. Gur, M.D., Ph.D.; Ruben C. Gur, Ph.D.
Controlling Neuronal Activity
M. Bret Schneider, M.D.; Viviana Gradinaru, B.Sc.; Feng Zhang, A.B.; Karl Deisseroth, M.D., Ph.D.
Karl Bonhoeffer (1868–1948)
Andreas Ströhle, M.D.; Jana Wrase, Ph.D.; Henry Malach, M.D.; Christof Gestrich, Ph.D.; Andreas Heinz, M.D.
Dietrich Bonhoeffer (1906–1945)
Andreas Ströhle, M.D.; Jana Wrase, Ph.D.; Henry Malach, M.D.; Christof Gestrich, Ph.D.; Andreas Heinz, M.D.
Doubt
Steven Ablon, M.D.